SearchDictionaryMobileLogin

Successful gene therapy via intraarticular injection of adenovirus vector containing CTLA4IgG in a murine model of type II collagen-induced arthritis.

AbstractWe previously constructed an adenovirus vector carrying a gene encoding a soluble form of fusion protein, consisting of the extracellular portion of cytotoxic lymphocyte antigen 4 (CTLA4) and the Fc portion of human immunoglobulin G1 (Adex1CACTLA4IgG). Murine type II collagen-induced arthritis (CIA) was treated with Adex1CACTLA4IgG. A single intraarticular injection of 1 x 10(5) PFU was able to support serum CTLA4IgG at more than 10 microg/ml for at least 12 weeks and was able to inhibit the CIA clinically and histologically. In contrast, intravenous, intramuscular, or subcutaneous injection of 1 x 10(5) PFU was unable to support a significant level of serum CTLA4IgG and thus was unable to inhibit the development of arthritis. Thus, we demonstrated that (1) a low-dose intraarticular injection of Adex1CACTLA4IgG was effective in delaying the onset of CIA and reducing the severity of arthritis; (2) an intraarticular (knee joint) injection of Adex1CACTLA4IgG effectively blocked the development of arthritis in distal paws; (3) the inhibitory effect of Adex1CACTLA4IgG lasted at least up to 20 weeks; (4) although serum CTLA4IgG at more than 10 microg/ml persisted for at least 12 weeks, mice treated by intraarticular injection of Adex1CACTLA4IgG were not anergic to adenovirus and were able to mount antibody responses against various antigens.
AuthorsK Ijima, M Murakami, H Okamoto, M Inobe, S Chikuma, I Saito, Y Kanegae, Y Kawaguchi, A Kitabatake, T Uede (Affiliation: Division of Molecular Immunology, Institute for Genetic Medicine, Hokkaido University, 060-0815 Sapporo, Japan.)
JournalHuman gene therapy (Hum Gene Ther) Vol. 12 Issue 9 Pg. 1063-77 (Jun 10 2001) ISSN: 1043-0342 United States
PMID11399228 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation
  • Immunoconjugates
  • Immunoglobulin Fc Fragments
  • Immunoglobulin G
  • abatacept
  • cytotoxic T-lymphocyte antigen 4
  • Collagen
Topics
  • Adenoviridae (genetics)
  • Animals
  • Antigens, CD
  • Antigens, Differentiation (administration & dosage, biosynthesis, genetics, therapeutic use)
  • Arthritis, Experimental (genetics, immunology, pathology, therapy)
  • Collagen (administration & dosage, immunology)
  • Disease Progression
  • Female
  • Gene Therapy (methods)
  • Genetic Vectors (administration & dosage)
  • Immunity, Natural (genetics)
  • Immunoconjugates
  • Immunoglobulin Fc Fragments (administration & dosage, biosynthesis, genetics)
  • Immunoglobulin G (administration & dosage, biosynthesis, genetics, therapeutic use)
  • Injections, Intra-Articular
  • Injections, Intramuscular
  • Injections, Intravenous
  • Injections, Subcutaneous
  • Mice
  • Mice, Inbred DBA
  • Severity of Illness Index